Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Q3 2020 Pacific Biosciences of California Inc Earnings Call Transcript

Nov 02, 2020 / 09:30PM GMT
Release Date Price: $13.25 (+1.07%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Pacific Biosciences of California, Inc. Third Quarter 2020 Earnings Conference Call. (Operator Instructions)

I would now like to turn the conference over to your host, Ms. Trevin Rard. Please go ahead.

Trevin Rard
Pacific Biosciences of California, Inc. - Head of IR

Thank you, Alexander. Good afternoon, and welcome to the Pacific Biosciences Third Quarter 2020 Conference Call. We hope that you are keeping well during this time. Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com, or alternatively, as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

With me today are Christian Henry, our Chief Executive Officer; Susan Kim, our Chief Financial Officer; and Ben Gong, our Vice

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot